Please fill in the form with your username, your password will be send to your registered e-mail.
* Mandatory fields
Website dedicated to help patients, their family and friends about the cancer immunotherapeutic approach in an easy-to-understand format.
Website providing information about the now recruiting Non-Small Cell Lung Cancer phase III clinical study
The immune response to a tumor antigen is a variant of the immune reaction to any antigen. Macrophages and natural killer cells may be important as effectors of this reaction, but an adequate cytotoxic reaction needs activation of both CD4+ helper cells and CD8+ T-cells plus production of cytokines and chemokines.
If this is your first time at this site, please click here to register.
Register now
For legal reasons, this page is intended solely for healthcare professionals. This is why we ask you to register.
© 2001 - 2008 GlaxoSmithKline plc. All rights reserved.